Literature DB >> 31776438

Crustal growth and reworking: A case study from the Erguna Massif, eastern Central Asian Orogenic Belt.

Chenyang Sun1,2, Wenliang Xu3,4, Peter A Cawood2, Jie Tang1,5, Shuo Zhao6, Yu Li7, Xiaoming Zhang1.   

Abstract

Despite being the largest accretionary orogen on Earth, the record of crustal growth and reworking of individual microcontinental massifs within the Central Asian Orogenic Belt (CAOB) remain poorly constrained. Here, we focus on zircon records from granitoids in the Erguna Massif to discuss its crustal evolution through time. Proterozoic-Mesozoic granitoids are widespread in the Erguna Massif, and spatiotemporal variations in their zircon εHf(t) values and TDM2(Hf) ages reveal the crustal heterogeneity of the massif. Crustal growth curve demonstrates that the initial crust formed in the Mesoarchean, and shows a step-like pattern with three growth periods: 2.9-2.7, 2.1-1.9, and 1.7-0.5 Ga. This suggests that microcontinental massifs in the eastern CAOB have Precambrian basement, contradicting the hypothesis of significant crustal growth during the Phanerozoic. Phases of growth are constrained by multiple tectonic settings related to supercontinent development. Calculated reworked crustal proportions and the reworking curve indicate four reworking periods at 1.86-1.78 Ga, 860-720 Ma, 500-440 Ma, and 300-120 Ma, which limited the growth rate. These periods of reworking account for the crustal heterogeneity of the Erguna Massif.

Entities:  

Year:  2019        PMID: 31776438      PMCID: PMC6881325          DOI: 10.1038/s41598-019-54230-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  1 in total

1.  Rollback, scissor-like closure of the Mongol-Okhotsk Ocean and formation of an orocline: magmatic migration based on a large archive of age data.

Authors:  Tao Wang; Ying Tong; Wenjiao Xiao; Lei Guo; Brian F Windley; Tatiana Donskaya; Shan Li; Narantsetseg Tserendash; Jianjun Zhang
Journal:  Natl Sci Rev       Date:  2021-11-29       Impact factor: 17.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.